Google DeepMind CEO Demis Hassabis disagrees with company's co-founder Sergey Brin on this one thing: 'We thought it was...'
Left: Google DeepMind CEO Demis Hassabis, Right: Google co-founder Sergey Brin
Google DeepMind
CEO
Demis Hassabis
holds a more cautious outlook on the arrival of
artificial general intelligence
(AGI) than the Alphabet-owned company's co-founder
Sergey Brin
. Currently, AGI's definition is contested, with some focusing on human-level competence across all domains and others on an AI's capacity to learn, adapt and produce autonomous outputs beyond its training data. Despite both having access to similar data and insights into AI development, Hassabis' perspective differs from Brin's. In a recent conversation on the New York Times' Hard Fork podcast, it was noted that Brin expects AGI to arrive before 2030, while Hassabis has predicted that it will happen just after 2030. This difference in forecasts raises questions about how these Google executives may be perceiving differently from the same information. Hassabis also stated that he is sticking to a timeline he has maintained since DeepMind was founded in 2010.
What Demis Hassabis has predicted about the arrival of AGI
Talking at the NYT podcast, Hassabis said:
'We thought it was roughly a 20-year mission, and amazingly, we're on track. It's somewhere around there, I would think.'
The prediction came after Brin jokingly accused Hassabis of 'sandbagging', which is intentionally downplaying timelines to later overdeliver. However, during the interview, Hassabis stood by his reasoning, pointing to the complexity of defining AGI itself.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
These Are The Most Beautiful Women In The World
5minstory.com
Undo
"I have quite a high bar. It should be able to do all of the things that the human brain can do, even theoretically. And so that's a higher bar than, say, what the typical individual human could do, which is obviously very economically important,'
Hassabis noted.
When asked whether AGI would emerge through gradual improvements or sudden breakthroughs, Hassabis said both approaches are 'likely necessary.'
'We push unbelievably hard on the scaling,'
he explained, while also funding 'blue sky' research such as
AlphaEvolve
.
Last year, Anthropic CEO
Dario Amodei
predicted that AGI could arrive by 2026 or 2027, though he warned that unforeseen factors might delay its development. Other industry leaders share similar optimism: OpenAI CEO Sam Altman has suggested AGI could materialise during Trump's presidency, and Ark Invest's Cathie Wood has argued it could become a major engine of economic growth.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
33 minutes ago
- Time of India
A Warning, 'Wish Elon Well' and ...: 7 Things that Donald Trump has said about Elon Musk after their BIG Fight
President Donald Trump is reportedly backing off his battle with Elon Musk. According to news reports, in a telephone interview with NBC News, when asked if his relationship with Tesla and SpaceX CEO was over, Trump said, "I would assume so, yeah." "No," Trump told NBC when asked if he had any desire to repair his relationship with Elon Musk. "I have no intention of speaking to him," Trump said. Donald Trump's warning to Elon Musk The President also issued a warning amid reports that Musk could back Democratic lawmakers and candidates in the 2026 midterm elections. 'If he does, he'll have to pay the consequences for that,' Trump reportedly told NBC. Trump, however, declined to say what those consequences would be, and went on to add that he had not had discussions about whether to investigate Musk. Donald Trump: Wish Elon Musk well by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo When asked about Elon Musk, Trump said, 'Honestly, I've been so busy working on China, working on Russia, working on Iran. I'm not thinking about Elon, and I just wish him well.' Donald Trump: Wish Tesla Well, and not thought of what to do with the Tesla he bought as yet When Trump was asked about Tesla, he said, "I hope Elon Musk does well with Tesla." On being asked more pointedly what he plans to do with the Tesla he bought to support Elon Musk in March, he said he has not yet thought of it. There have been speculations that the President plans to sell his Tesla. Donald Trump is not taking the key he gifted to Elon Musk back President Trump said he won't take back the White House key he gifted to Elon Musk just days ago. Donald Trump on Elon Musk being called a drug addict: Sounds Unfair Responding to a New York Times article about Elon Musk's alleged drug use, Trump said, "I don't want to comment on this news, I don't know what his status is and I read an article in The New York Times and I thought it was, frankly it sounded very unfair to me." President Trump on canceling Elon Musk's contracts "We'll take a look at everything. He's got a lot of money. He gets a lot of subsidies, so we'll take a look at that only if it's fair for him and for the country. I would certainly think about it yeah but it has to be fair." AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
38 minutes ago
- Time of India
Ayurvedic & herbal products manufacturers in Indore ramp up production as Covid cases increase
Indore: As Covid-19 cases are witnessing an uptick, manufacturers of Ayurvedic and herbal products in Indore have ramped up their production capacities, anticipating a surge in demand for immunity-boosting products. Usually, summers remain the lean season for immunity booster syrups and tablets, but the resurgence of Covid-19 cases led to a jump in enquiries, prompting many units to prepare for increased production ahead of their usual season. Ayush Nirmata Sangh secretary Ashish Dubey said, "We are anticipating a surge in demand for immunity boosters as cases of Covid-19 again started to increase. Many units started preparations and are gradually increasing production." Another manufacturer owner of a local Ayurvedic firm Ravi Kumar said, "We saw an increase in enquiries for our immunity products. To meet this demand, we are expanding our operations to ensure we can deliver quality products to our customers promptly. Also, monsoon and winters are main demand period of Ayurvedic products when demand rises." Industry insiders noted that if the consumption of these products would not meet their expectations, they would still find a market during the monsoon and winter seasons when the demand for syrups and immunity boosters typically spikes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Ayurvedic products produced in Indore are distributed across various states in India, including Delhi, Punjab, Maharashtra, Uttar Pradesh, and Uttarakhand, according to local manufacturers. In response to the heightened demand, many manufacturing units are transitioning to automatic production processes, while others are opting for semi-automatic configurations to enhance efficiency. Indore is home to around 240 Ayurvedic medicine manufacturing units, with the total market size exceeding an impressive Rs 1000 crore, as reported by Ayush Nirmata Sangh.
Time of India
38 minutes ago
- Time of India
Procurement rules for scientific research eased
Mumbai: In a resounding shift, the ministry of finance eased a long-standing bottleneck in procurement rules that once tethered researchers to the govt e-Marketplace (GeM), now allowing them to source scientific equipment and consumables from outside it. The revision in monetary ceilings and procurement channels, officials say, required the direct intervention of Prime Minister Narendra Modi. For the scientific community, this isn't just administrative reform—it's an acknowledgment and a huge relief. "Science cannot be caged in platforms and progress cannot always be L1," said a frustrated scientist, who said procurement was running into long delays because of cost and quality issues. The spirit behind GeM portal is, in principle, noble, said most scientists—designed to uplift Indian suppliers and foster a self-reliant manufacturing ecosystem. "But behind the digital veneer of transparency and procurement lies a troubling reality." "As a scientist, I ask—what truly serves the nation? If I want to order a computer that serves my requirements today, I cannot buy one unless it is L1," said professor at the School of Biotechnology at Jawaharlal Nehru University, Binay Panda. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Most Successful Way of Intraday Trading is "Market Profile" TradeWise Learn More Undo Five amendments have been made to existing procurement rules. Vice-Chancellors and directors of India's top scientific and academic institutions no longer have to wait for clearances to procure scientific equipment and consumables for research. Under the newly eased rules, they now hold the power to approve Global Tender Enquiries—up to a staggering Rs 200 crore—if they believe the need is justified. No central nod, no extra scrutiny. Just their judgment. Similarly, the ceiling for direct purchases—those made without quotations—has been raised from Rs 1 lakh to Rs 2 lakh. And what once required a drawn-out trail of tenders—purchases from Rs 1 to 10 lakh—can now be cleared by a purchase committee for anything up to Rs 25 lakh. Additionally, the limits on limited tender enquiry have been lifted—from Rs 50 lakh to Rs 1 crore. And perhaps, most telling of all, said scientists—the need for open tenders—earlier triggered at Rs 50 lakh—will now apply only to purchases above Rs 1 crore. Minister of State for Science and Technology, Jitendra Singh, took to social media and termed this as "a landmark step" for enabling #EaseOfDoingResearch. "This will reduce delays, also enhance autonomy and flexibility for research institutions—empowering them to innovate faster," he added. Secretary of the Department of Science and Technology, Prof Abhay Karandikar, said, "It was made possible by the collective efforts of everyone, including other scientific secretaries, PSA, Department of Expenditure and Cabinet Secretariat. " Another scientist explained that in this "algorithm-driven marketplace, the lowest bidder always wins, never mind if the product fails the test of quality. What use is cost-efficiency if it sacrifices precision and most importantly, the requirements of a scientific experiment? What use is patriotism if it's only glued on?" "They don't really make these products here," added Prof Panda. "They import many parts, assemble them locally, and slap on a Make in India sticker—as if that alone sanctifies the machine." He quickly added, "If there is a good Indian product, we do not think twice. We prefer make-in-India by default—it's more affordable, support is better, and it's close by." Most scientists echoed this. However, "We don't want to buy an Indian product if science suffers. "
